Clinical Trials Browser

Carcinoma, Squamous Cell × olaparib × 90 days × Clear all

NCT05366166 2026-01-28

Pembrolizumab Plus Olaparib in LA-HNSCC

Phase 2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell